Avanos Medical Inc (AVNS)

R&D Expense Growth

-14.75%

Quarterly · Period ending:

AVNS logo

AVNS R&D Expense Growth

Latest reported-14.75%
AVNS Quarterly R&D Growth (QoQ) (0.00% → -14.75%)
High-resolution chart · PNG

AVNS r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Avanos Medical Inc R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
-14.7541%
5.1724%
0%
7.4074%
-5.2632%
-20.8333%
14.2857%
-10%
2.9412%
11.4754%
-10.2941%
-13.9241%
5.3333%
2.7397%
-8.75%
2.5641%
2.6316%
-9.5238%
5%
-3.6145%
-13.5417%
17.0732%
6.4935%
-18.0851%
11.9048%
-12.5%
1.0526%
-6.8627%
-3.7736%
0.9524%
-2.7778%
9.0909%
-18.1818%
26.0417%
4.3478%
15%
-33.3333%
10.0917%
14.7368%
9.1954%
-11.2245%
-3.9216%
61.9048%
5%
-20%
-11.7647%
-8.6022%
12.0482%
-39.4161%
53.9326%
14.1026%
4%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.